High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance-Reference-Cited by-同舟云学术

High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance

Published:2017-05-10 Issue:9 Volume:41 Page:1341-1347
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

Cai J,Wu C H,Zhang Y,Wang Y Y,Xu W D,Lin T C,Li S X,Wang L H,Zheng J,Sun Y,Liu W,Tao T

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://www.nature.com/articles/ijo2017116.pdf

Reference38 articles.

1. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R . Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011; 7: 219–231.

2. Brzozowska MM, Ostapowicz G, Weltman MD . An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. J Gastroenterol Hepatol 2009; 24: 243–247.

3. Boudreaux MY, Talbott EO, Kip KE, Brooks MM, Witchel SF . Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up. Curr Diab Rep 2006; 6: 77–83.

4. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health—National Heart, Lung, and Blood Institute sponsoredWomen’s Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008; 93: 1276–1284.

5. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005–2023.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay;Journal of Clinical Medicine;2024-07-20

2. Inhibition of the glucocorticoid‐activating enzyme 11β‐hydroxysteroid dehydrogenase type 1 drives concurrent 11‐oxygenated androgen excess;The FASEB Journal;2024-03-29

3. Polycystic ovary syndrome and nonalcoholic fatty liver disease;Polycystic Ovary Syndrome;2024

4. Metabolic comorbidities, endocrine—Diabetes, polycystic ovarian syndrome, thyroid dysfunction;Metabolic Steatotic Liver Disease;2024

5. Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma;iScience;2023-12